Choksi Laboratories Approves ₹6.20 Crore Preferential Warrant Issue to Promoters
Choksi Laboratories Ltd · Outcome · 19 Sept 2026, 9:47 pm
Choksi Laboratories Approves ₹6.20 Crore Preferential Warrant Issue to Promoters Choksi Laboratories' board approved the preferential issuance of up to 3,50,000 convertible equity warrants at Rs. 177 per warrant, aggregating up to Rs. 6.195 crore to promoter group members Sunil Choksi (2,00,000), Himika Choksi (1,00,000), and Stela Choksi (50,000). The issue requires 25% upfront subscription, with the 75% balance payable upon exercise within 18 months. Fully diluted promoter holding will rise accordingly, subject to shareholder approval at the EGM scheduled for 17th Oct'26.
Original exchange filing (PDF)
More announcements from Choksi Laboratories Ltd
- Considered and approved the Unaudited Financial Results for the quarter and half year ended on 30th September,2026 along with the Limited Review Report · 14 Nov 2026
- 1. Considered and approved the Unaudited Financial Results for the Quarter and Half Year ended on 30th September, 2026 along with the Limited review report; 2. The Board has also discussed .... · 14 Nov 2026
- Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve 1. To consider and approve .... · 14 Nov 2026
- Intimation under Regulation 30 is attached herewith. · 03 Nov 2026
- We are enclosing herewith clarification on delay in submission with respect to proceedings of EGM · 22 Oct 2026
- Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding non approval of proposed preferential issue of convertible warrants and request for closure of application for .... · 19 Oct 2026
- The voting result along with the scrutinizer report the e-voting and remote e-voting held at EGM of the company held on 17.10.2026. · 19 Oct 2026
- Summary of proceedings of EGM enclosed herewith · 18 Oct 2026
